drugset / Trial / NCT07667829

Vasopressor Agents in Pulmonary Hypertension Crisis

NCT07667829

Not yet recruiting 75 enrolled China National Center for Cardiovascular Diseases
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of the efficacy and safety of three vasoactive agents-dopamine, norepinephrine, and epinephrine-in the treatment of patients with pulmonary hypertension crisis: prospective, randomised controlled trial monitored by haemodynamic monitoring

Timeline

Start
2026-06
Primary completion
2028-12-31
Completion
2029-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dopamine Small molecule 2 ug/kg
Subject Epinephrine Other / unclassified 0.02 ug/kg
Subject Norepinephrine Other / unclassified 0.02 mg/kg